Web Results


Valsartan: Preclinical and Clinical Profile of an Antihypertensive Angiotensin‐II Antagonist. Leoluca Criscione. Research and Development Department, ...


The pharmacology of valsartan has been reviewed (Criscione et al 1993; Markham and .... Third, the V-HeFT group (Baruch et al 1999) previously demonstrated ...


Apr 17, 2012 ... The study of Sasano et al. and our findings suggest that the underlying ... Hurley S, Kleiman J, Gatlin M. Eplerenone, a selective aldosterone blocker, ... Oskouei B , Centola M, Eneboe V, Young R, Lima JA, Lardo AC, Heldman AW, Hare JM. ... [ PubMed] [Cross Ref]; Zimmerman SD, Criscione J, Covell JW.


a residual effect was found with all 3 drugs, but at 30 hours, only irbesartan induced a marked, ..... lower than that reported by Muller et al.8 However, in our.


Hansson L; Lindholm LH; Niskanen L; et al. ... JT; et al. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. .... Pool JL; Glazer R; Chiang YT; Gatlin M ... Criscione L; Bradley W; Buhlmayer P; et al.


Nov 28, 2012 ... All dosages of valsartan significantly reduced blood pressure compared with placebo. One of these trials evaluated the 24-hour blood pressure ...


Dec 30, 2016 ... Gatlin v. P.O.A. Criscione Star #16195,. 2008 WL 2745956 . ...... of the United States and Canada, AFL-CIO, et al. v. Arkansas Glass Container ...


It is therefore likely that all major parasites play a role as selective factors in shaping the evolution of the ...... 5Williams‐Blangero, S, Criscione, CD, VandeBerg, JL et al. ..... 62Gatlin, MR, Black, CL, Mwinzi, PN et al. .... 93Junpee, A, Tencomnao, T, Sanprasert, V, and Nuchprayoon, S. Association between Toll‐ like receptor 2 ...